| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/14/2008 | WO2008065543A2 Modified soluble fgf receptor fc fusions with improved biological activity |
| 08/14/2008 | WO2008060780A3 Glycerol linked pegylated sugars and glycopeptides |
| 08/14/2008 | WO2008050363A8 Use of thymosin alpha 1 for the preparation of a medicament for the prevention and treatment of autoimmune diseases |
| 08/14/2008 | WO2008033557A3 Click chemistry-derived cyclic peptidomimetics as integrin markers |
| 08/14/2008 | WO2008033499A3 Modulation of regulatory t cells by human il-18 |
| 08/14/2008 | WO2008015383A3 Bmp-9 and bmp-10 and their use in breast and prostate cancer therapies |
| 08/14/2008 | WO2007109293A3 Early diagnosis of congenital abnormalities in the offspring of diabetic mothers |
| 08/14/2008 | WO2007084895A3 Peptide-based regulation of gap junctions |
| 08/14/2008 | WO2006002253A3 Native soft tissue matrix for therapeutic applications |
| 08/14/2008 | US20080196113 Lipocalin Protein |
| 08/14/2008 | US20080194806 Use of lipid conjugates in the treatment of diseases |
| 08/14/2008 | US20080194800 Human Receptor Proteins; Related Reagents and Methods |
| 08/14/2008 | US20080194799 Modified Chimeric Polypeptides with Improved Pharmacokinetic Properties |
| 08/14/2008 | US20080194797 Leucine-based motif and clostridial neurotoxins |
| 08/14/2008 | US20080194697 ethyl endcapped hepta- and nona-tetramethylenediamines and 1,2-bis(4-(ethylamino)butylaminomethyl)cyclopropane, used for treating prostate cancer, prostatitis and benign prostatic hyperplasia |
| 08/14/2008 | US20080194692 Polymorphs of suberoylanilide hydroxamic acid |
| 08/14/2008 | US20080194683 Medicament for preventing and/or treating peripheral neuropathies |
| 08/14/2008 | US20080194682 administering inhibitors of endopeptidase such as thiorphan or candoxatril, to effect bone elongation; achondroplasia |
| 08/14/2008 | US20080194666 Gonadotropin-releasing hormone antagonist (GnRH antagonist); insecticides, nematocides and molluscicides; sexual disorders |
| 08/14/2008 | US20080194515 Extracting DNA from a blood or buccal cell sample, PCR, resolution, and identification of differences in sequences between the extracted DNA and PCR primers; drug screening |
| 08/14/2008 | US20080194514 Methods and Compositions for Inhibiting the Function of Polynucleotide Sequences |
| 08/14/2008 | US20080194512 Compositions and methods for inhibiting viral replication |
| 08/14/2008 | US20080194503 Antisense Modulation of P38 Mitogen Activated Protein Kinase Expression |
| 08/14/2008 | US20080194493 Compositions Containing D-Carnosine |
| 08/14/2008 | US20080194492 Use of gamma-glutamyl-peptide for example gamma-L-glutamyltrans-S-1-propenyl-L-cysteine sulfoxide (GPCS); Paget's disease, tumor-induced bone disease or osteoporosis; ethanolic extract of allium such as Allium cepa (onion); nutraceuticals |
| 08/14/2008 | US20080194491 Methods of Diagnosing, Preventing, and Treating Early Onset of Pulmonary Hypertension |
| 08/14/2008 | US20080194490 At4 receptor ligands as angiogenic, anti-angiogenic, and anti-tumor agents |
| 08/14/2008 | US20080194489 i.e., problems or complications resulting from a medical treatment with oligopeptides of given sequence, for example LAGV, VLPALPQ, AQGV, or LQGV; human chorionic gonadotropin (hCG) derived gene-regulatory peptides |
| 08/14/2008 | US20080194488 Orally active peptides that prevent cell damage and death |
| 08/14/2008 | US20080194487 Use of Substance P or its analogs topically to treat eczema, psoriasis, acne, or basal cell carcinoma |
| 08/14/2008 | US20080194486 Novel Anti-Obesity Agents |
| 08/14/2008 | US20080194485 Use of a prolylcarboxypeptidase (PRCP) inhibitor to treat or prevent obesity; use for example t-butyl carbamate-prolyl prolinal (B-PP), N-benzyloxycarbonyl-prolyl-prolinal (Z-PP), diisopropyl fluorophosphate, PMSF, antipain, leupeptin, corn trypsin, and mercuric chloride |
| 08/14/2008 | US20080194484 Truncated Motilin-Like (TML) peptides; use modulating contractility in duodenum or jejunum tissue and pancreatic secretion of hormones and digestive enzymes |
| 08/14/2008 | US20080194483 GLP-1 (9-36) methods and compositions |
| 08/14/2008 | US20080194482 VPAC2 receptor peptide agonists of given amino acid sequences; PACAP-preferring type 2 (PAC2) receptor; VIP-shared type 2 receptors (VPAC2); induce insulin secretion from the pancreas only in the presence of high blood glucose levels; side effect reduction; diabetes |
| 08/14/2008 | US20080194481 Albumin Fusion Proteins |
| 08/14/2008 | US20080194480 Polypeptide for reducing the growth rate of cancer cells; polypeptide of given sequence that is down-regulated in cancer |
| 08/14/2008 | US20080194479 AMP-18 derived peptide to treat oral mucositis; Antrum Mucosal Protein (AMP)-18 (also called gastrokine-1); delays the onset or duration of mucositis, including cancer therapy-induced mucositis |
| 08/14/2008 | US20080194478 Wound healing agent and composition |
| 08/14/2008 | US20080194477 Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules |
| 08/14/2008 | US20080194476 Medicament Comprising A Peptide Extract Of Avocado, Which Is Intended For The Treatment And Prevention Of Illnesses That Are Linked To An Immune System Deficiency |
| 08/14/2008 | US20080194475 mutant erythropoietin (EPO) having improved stability as measured by a ratio of the ability of an EPO variant to bind the EPO receptor in the presence of dithiothreitol (DTT), in a radioimmunoassay, versuses the ability in the absence of DTT in the same radioimmunoassay |
| 08/14/2008 | US20080194474 Increasing the population of HSA+/Ly6C+ cells in bone marrow with Fms-like tyrosine kinase 3 ligand (Flt3-Ligand); preventing or delaying type I diabetes, rheumatoid arthritis, lupus, multiple sclerosis, psoriasis, scleroderma, inflammatory bowel diseases, or myasthenia gravis; bone marrow transplant |
| 08/14/2008 | US20080194473 Intraventricular administration of hepatocyte growth factor (HGF) |
| 08/14/2008 | US20080194472 Use of Fgf-18 Protein, Target Proteins and Their Respective Encoding Nucleotide Sequences to Induce Cartilage Formation |
| 08/14/2008 | US20080194471 Compositions and Methods for Treating Wounds |
| 08/14/2008 | US20080194470 Nim811 In Cerebral Ischemia and Brain and Spinal Cord Injury |
| 08/14/2008 | US20080194469 Biodrug such as eptifibatide with blend of a hydrolyzable hydrophobic polymer containing diphenolic tyrosine monomer such as poly(desaminotyrosyltyrosine hexyl ester adipate (Poly(DTH adipate)), and another less hydrophobic hydrolyzable polymer that degrades to form acidic groups, releasing the biodrug |
| 08/14/2008 | US20080194468 Transporter-enhanced corticosteroid activity and methods and compositions for treating dry eye |
| 08/14/2008 | US20080194467 Cancer treatment methods using cadherin antagonists in combination with anticancer agents |
| 08/14/2008 | US20080194466 (5Z)-5-(6-Quinoxalinylmethylidene)-2-[(2,4,6-Trichlorophenyl)Amino]-1,3-Thiazol-4(5H)-One |
| 08/14/2008 | US20080194465 Cross-linked glycopeptide-cephalosporin antibiotics |
| 08/14/2008 | US20080194464 Chemical intermediate thereto; effective against antibiotic-resistant strains of bacteria, such as methicillin-resistant Staphylococci aureus (MRSA) |
| 08/14/2008 | US20080194463 Antibacterial antisense oligonucleotide and method |
| 08/14/2008 | US20080194462 Methods and Compositions for Treatment of Autoimmune Diseases |
| 08/14/2008 | US20080194461 Stabilizing Alkylglycoside Compositions and Methods Thereof |
| 08/14/2008 | US20080194460 Fusion polypeptide capable of binding vascular endothelial growth factor (VEGF), wherein polypeptide consists of immunoglobulin-like (Ig) domain 2 of a first VEGF receptor and Ig domain 3 of a second VEGF receptor and multimerizing component; use in decreasing or inhibiting plasma leakage; eye disorders |
| 08/14/2008 | US20080194459 Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides |
| 08/14/2008 | US20080194458 Phospholipid, higher alcohol, and higher aliphatic acid; free of protein and peptide; respiratory disorders |
| 08/14/2008 | US20080194457 Frizzled Proteins and Detection and Treatment of Cancer |
| 08/14/2008 | US20080194456 Drug screening; inflammatory bowel disease; Crohn's disease |
| 08/14/2008 | US20080193949 Using selectin concentration as diagnostic indicator of thrombosis |
| 08/14/2008 | US20080193944 Expression vector comprising nucleotide sequences coding cardiac-related ankyrin-repeat protein kinase (CARK) for diagnosis, treatment and prevention of cardiovascular disorders |
| 08/14/2008 | US20080193939 Corneodesmosin based test and model for inflammatory disease |
| 08/14/2008 | US20080193920 Methods and systems for producing recombinant viral antigens |
| 08/14/2008 | US20080193573 Using supercritical carbon dioxide extraction method; reduce amyloid plaque aggregate; Alzheimer's disease |
| 08/14/2008 | US20080193546 Solid dose delivery vehicle and methods of making same |
| 08/14/2008 | US20080193545 Use of Glycerol Dipalmitostearate for Improving the Bioavailability of Protein Active Ingredients in Subcutaneous or Intramuscular Injectable Formulations |
| 08/14/2008 | US20080193516 Oxygen-carrying blood substitute preparations |
| 08/14/2008 | US20080193515 Overexpression of Wnt ligands and treatment of lytic bone diseases |
| 08/14/2008 | US20080193510 Nucleic acids, peptides, and antibodies for use in diagnosis and therapy; macular degeneration; cancers of the colon, breasts, prostate, liver, pancreas, and mouth; receptor binding assays of the peptide to neovasulatures |
| 08/14/2008 | US20080193507 Wound Healing Profile |
| 08/14/2008 | US20080193504 After cataract surgery; an intraocular lens implant coated with a p38 kinase inhibitor of SB203580 or SB202190, an ERK kinase inhibitor of U0126 or PD98059, or a Src family kinase inhibitor of 4-amino-5-(4-methylphenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine, SK1606 or SU6656; extended release formulations |
| 08/14/2008 | US20080193501 Synergistic; proliferative agents for bone and nervous tissue; can also include an antiinflammatory agent to treat rheumatoid or osteoarthritis; time-release formulations in dosage forms of solutions, gels, pastes or putties |
| 08/14/2008 | US20080193500 Aggrecan; collagen; heteropolysaccharide in extracellular matrix |
| 08/14/2008 | US20080193499 Inosine-monophosphate dehydrogenase inhibitor, clotrimazole, fluconazole, trifluridine, danazol, and asparaginase; sustained release; kits |
| 08/14/2008 | US20080193491 Diaminooxidase-Containing Pharmaceutical Compositions |
| 08/14/2008 | US20080193488 Variant Polypeptide and Screening Assay |
| 08/14/2008 | US20080193487 Preparation for Vaccination, Vaccination Method and Use of a Vaccination Preparation |
| 08/14/2008 | US20080193472 Influenza vaccine formulation |
| 08/14/2008 | US20080193470 Proteins and Nucleic Acids from Meningitis/Sepsis-Associated Escherichia Coli |
| 08/14/2008 | US20080193469 Contraceptives Based on Sp22 and Sp22 Antibodies |
| 08/14/2008 | US20080193467 Dendritic cell potentiation |
| 08/14/2008 | US20080193463 Combating the pathogenic effects of Mycoplasma infection in an animal by administering an effective amount of isolated and purified mycoplasmal L-alpha-glycerophosphate oxidase or an immunogenic fragment thereof, and a pharmaceutically acceptable carrier |
| 08/14/2008 | US20080193462 Inhibiting tumor cell growth in subject by administering to said subject a combination of a cytotoxic or a chemotherapeutic agent and a composition comprising an insulin-like growth factor receptor-1 (IGF-1R) inhibitor; demonstrating specific approaches to enhance therapeutic window of IGF-1R inhibition |
| 08/14/2008 | US20080193459 Treatment of fungal infections with polyene or beta glucan synthase inhibitor anti-fungals combined with anti HSP90 antibodies |
| 08/14/2008 | US20080193458 125p5c8: tissue specific protein highly expressed in various cancers |
| 08/14/2008 | US20080193457 Major histocompatibility complex peptide for use in treatment and prevention of rheumatoid arthritis (RA) |
| 08/14/2008 | US20080193454 Identification of Surface-Associated Antigens for Tumor Diagnosis and Therapy |
| 08/14/2008 | US20080193447 Gamma-1 and gamma-3 anti-human cd23 monoclonal antibodies and use thereof as therapeutics |
| 08/14/2008 | US20080193444 Methods of suppressing LTP inhibition |
| 08/14/2008 | US20080193441 Homogeneous Preparations of Chimeric Protein |
| 08/14/2008 | US20080193440 Method For Multiple Sclerosis Treatment and Prophylaxis By Treatment of Leptospira Infection |
| 08/14/2008 | US20080193437 Two oligonucleotides each containing 2'-deoxy-7-deazaguanosine and linked by a non-nucleotide linker and where the sequences are at least partially self-complementary; anticarcinogenic agents; antiinflammatory agents; autoimmune diseases; antiallergens asthma; disease; gene therapy; vertabrates |
| 08/14/2008 | US20080193436 Therapeutic mixture comprising myxococcus prolyl endopeptidases (PEP) for use in treatment and prevention of gluten intolerance, celiac sprue and/or dermatitis herpetiformis |
| 08/14/2008 | US20080193435 Using tryptophanyl-tRNA synthetase as therapeutic in promoting repair of damage associated ischemic events associated with vision |
| 08/14/2008 | US20080193434 Self-Directing And Self-Assembling Nanomedicine Into Quantized Conductance Junctions And Its Process |
| 08/14/2008 | US20080193433 Water free of pathogens, pyrogens, heavy metals, and viruses, sprouted grain comprising digestive enzymes and undenatured whey protein; glutathione, triozyme; cancer, hepatitis and human immunodeficiency virus |
| 08/14/2008 | US20080193431 Conjugate comprising substrate linked to cell death protease recognition sequence, photoactivatable killing agent and quencher; decontaminating blood, treating cancer or viral infections |
| 08/14/2008 | US20080193428 Benzoic acid or its sodium salt, saccharide, bactericide or antibiotic; glucose, fructose, mannose water-soluble gels, capsules; cleaning product, deodorizing agent |